InvestorsHub Logo
Followers 44
Posts 3794
Boards Moderated 0
Alias Born 11/16/2011

Re: investordisciple post# 23224

Saturday, 06/23/2012 8:53:58 AM

Saturday, June 23, 2012 8:53:58 AM

Post# of 335381
I agree investordisciple. There's a lot of great info here that should be stickied (updated) in the ibox. One of my favorite parts is the one about FDA Allay and the BIEL consultants representing them at the FDA meeting on June 8th. Even bashers must shamefully admit that their credentials couldn't be any better to represent BIEL. IMO.
"We were pleased with the Friday, June 8, meeting with the FDA. At the meeting we addressed the application of the technology to support our menstrual pain medical claim for Allay.
Dr. Kenneth McLeod, our consulting biophysics expert, made the technical presentation. Dr. McLeod received his PhD from MIT in electrical engineering, with a dissertation focused on electrophysiological properties of living tissue, and has worked in the field of bioelectromagnetics for more than 30 years. He is currently Director of the Clinical Science and Engineering Research Center at Binghamton University where the research is largely focused on functional disorders (such as chronic pain) and interventions to address these disorders. BioElectronics’ Chairman, Dr. Richard Staelin, is a mathematician and statistician, and was in attendance to support the clinical data analysis. Andrew Whelan was also in attendance at the meeting."